Obesity Drugmaker Leads 2 Biotech Startups Eyeing IPOs
Two biotechnology startup companies on Monday filed plans for their public debuts, with obesity-focused Kailera Therapeutics planning to raise an estimated $500 million in its initial public offering and protein biomarker...To view the full article, register now.
Already a subscriber? Click here to view full article